Skip to search formSkip to main contentSkip to account menu

Remission Induction

Known as: Remission Inductions, Induction, Remission, Induction of Remission 
Therapeutic act or process that initiates a response to a complete or partial remission level.
National Institutes of Health

Related topics

Related topics

2 relations
Disease-Free SurvivalRemission, Spontaneous

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up
Eight-year event-free survival (EFS) was evaluated in 205 patients with acute lymphoblastic leukemia (ALL), to consider the… 
2001
2001
Fludarabine, Arabinosyl Cytosine and Idarubicin (FLAI) for Remission Induction in Poor-Risk Acute Myeloid Leukemia
Progress in treatment of acute myeloid leukemia (AML) is slow and treatment intensification alone has limited effects… 
1999
1999
Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia
We have used a combination of flow cytometric assays to define multidrug resistance (MDR) positive and negative blasts in… 
Highly Cited
1995
Highly Cited
1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
Eighteen French centers reported 133 autologous stem cell transplantations performed after first remission induction in multiple… 
1992
1992
Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic…
Sequential molecular and cellular changes during remission induction were investigated in a case of acute promyelocytic leukemia… 
Highly Cited
1987
Highly Cited
1987
Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia.
In this study, it has been shown that in 21 patients with AML the dCyd kinase and dCyd deaminase activities correspond closely to… 
1985
1985
A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia.
While differentiation of leukemic cells in vitro is well established, the role of differentiation in vivo is not defined and is… 
Highly Cited
1979
Highly Cited
1979
Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL.
In 163 children with acute nonlymphocytic leukemia (ANLL), a D-ZAPO induction program consisting of daunomycin, 5-azacytidine… 
Highly Cited
1978
Highly Cited
1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with…
Vindesine, an analog of vinblastine and vincristine, has been submitted to a phase II trial, the results of which are judged in… 
1977
1977
Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone.
Fifty-six untreated patients with childhood with acute lymphoblastic leukemia (ALL) were randomized to receive one of three… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)